FYERS
Glenmark Pharmaceuticals2432.60
-26.40 (-1.07%)

Glenmark Pharmaceuticals Share Price

2432.60-26.40 (-1.07%)
+21.36% past 1 Year

Shareholding summary

Promoters
46.65%
FII
20.89%
DII
1.84%
MF
16.76%
Others
13.86%
Promoters
FII
DII
MF
Others
Quarterly
Yearly

Shareholding Pattern

Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
46.65%46.65%46.65%46.65%46.65%46.65%
20.89%20.35%19.20%20.73%20.62%23.15%
1.84%2.48%2.23%2.30%2.09%1.74%
16.76%16.80%17.86%16.31%15.55%12.86%
13.86%13.72%14.06%14.01%15.09%15.60%

Bulk & block deals

Name
Graviton Research Capital Llp
Graviton Research Capital Llp
Integrated Core Strategies (Asia) Pte. Ltd.
Ubs Ag
Ubs Ag
Ubs Principal Capital Asia Limited
Ishares Core Msci Emerging Markets Etf
Ishares Msci India Small-Cap Etf
Ishares Core Emerging Markets Mauritius Co
Ishares India Sc Mauritius Company
Deal DateActionDeal ValueDeal PriceQty TradedDeal Type%Stake TradedExchange
11 Jul 2025Purchase328.05 Cr₹2,171.6715.11 LBulk0.535244NSE
11 Jul 2025Sell328.30 Cr₹2,173.3115.11 LBulk0.535244NSE
25 Mar 2025Purchase39.48 Cr₹1,492.652.64 LBlock0.093707NSE
25 Mar 2025Sell39.48 Cr₹1,492.652.64 LBlock0.093707NSE
23 Jan 2025Purchase101.38 Cr₹1,5106.71 LBlock0.237893NSE
23 Jan 2025Sell101.38 Cr₹1,5106.71 LBlock0.237893NSE
25 Oct 2022Purchase12.04 Cr₹397.903.03 LBlock0.107227BSE
25 Oct 2022Purchase1.56 Cr₹397.9039.27 KBlock0.013913BSE
25 Oct 2022Sell12.04 Cr₹397.903.03 LBlock0.107227BSE
25 Oct 2022Sell1.56 Cr₹397.9039.27 KBlock0.013913BSE

Insider trading & SAST

Client name
Hdfc Mutual Fund
Mr. Praveen D Kurkal
Mr. Praveen D Kurkal
Mr. Praveen D Kurkal
Mr. Praveen D Kurkal
Mr. Praveen D Kurkal
Mr. Praveen D Kurkal
Hsbc Global Asset Management (Hong Kong) Ltd
Robin Pinto
Sridhar Gorthi
Reported onClient categoryAction%Stake tradedHolding % post dealDeal valueDeal priceQty tradedDeal periodDeal modePost transaction holdingInsider/SASTRegulation typeSecurity type
08 Jul 2025OtherAcquisition0.135.070—3.57 L17 Jun 2025Market1,43,05,181SAST29(1)—
25 Sep 2023Designated PersonDisposal0.00017704.26 L₹851.0250020 Sep 2023Market Sale2,590Insider Trading—Equity Shares
25 Sep 2023Designated PersonDisposal0.00035408.52 L₹8521 K20 Sep 2023Market Sale590Insider Trading—Equity Shares
25 Sep 2023Designated PersonDisposal0.00035408.52 L₹8521 K20 Sep 2023Market Sale1,590Insider Trading—Equity Shares
25 Sep 2023Designated PersonDisposal0.00017704.26 L₹851.0250020 Sep 2023Market Sale2,590Insider Trading—Equity Shares
25 Sep 2023Designated PersonDisposal0.00035408.52 L₹8521 K20 Sep 2023Market Sale590Insider Trading—Equity Shares
25 Sep 2023Designated PersonDisposal0.00035408.52 L₹8521 K20 Sep 2023Market Sale1,590Insider Trading—Equity Shares
12 Apr 2023—Disposal0.073.040—2.16 L06 Apr 2023Market85,97,867SAST29(2)—
24 Nov 2021Promoter GroupAcquisition0.0000890.181.23 L₹490.1925023 Nov 2021Market Purchase4,97,500Insider Trading—Equity Shares
17 Nov 2021DirectorDisposal0.00019802.99 L₹535.6855915 Nov 2021Market Sale0Insider Trading—Equity Shares

Glenmark Pharmaceuticals Ltd Share Price Today

The Glenmark Pharmaceuticals Ltd share price today is ₹2,442.80. During the trading session, the Glenmark Pharmaceuticals Ltd share price opened at ₹2,470.00 and recorded an intraday high of ₹2,471.80 and a low of ₹2,432.40. Last closing price was ₹2,460.00. Over the past 52 weeks, the Glenmark Pharmaceuticals Ltd share price has ranged between ₹1,792.60 and ₹2,537.60. The current Glenmark Pharmaceuticals Ltd stock price reflects real-time market activity based on executed trades on the exchange.